相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Diabetic retinopathy for the non-ophthalmologist
Timothy H. M. Fung et al.
CLINICAL MEDICINE (2022)
GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation
Ashok Mayendraraj et al.
PEPTIDES (2022)
Circ_0001897 regulates high glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p/transforming growth factor beta 2 axis
Yudan Gong et al.
BIOENGINEERED (2022)
GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway
Liufeng Wei et al.
JOURNAL OF DIABETES RESEARCH (2022)
Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease
Xiangwei Song et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
HbA(1c) Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
M. Angelyn Bethel et al.
DIABETES CARE (2021)
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
Kuan-Yu Lin et al.
JOURNAL OF DIABETES INVESTIGATION (2021)
Exendin-4 Protects Human Retinal Pigment Epithelial Cells from H2O2-Induced Oxidative Damage via Activation of NRF2 Signaling
Renzhe Cui et al.
OPHTHALMIC RESEARCH (2020)
Exendin-4, a GLP-1 receptor agonist regulates retinal capillary tone and restores microvascular patency after ischaemia-reperfusion injury
Ruyi Zhai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Screening for diabetic retinopathy: new perspectives and challenges
Stela Vujosevic et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
Vincenza Bonfiglio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway
Francesca Lazzara et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages
Giuseppe Caruso et al.
ANTIOXIDANTS (2019)
Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication
Cheng Hu et al.
DIABETES (2018)
Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expression
Ko-Hsun Liao et al.
PLOS ONE (2017)
Mechanistic Insights into Pathological Changes in the Diabetic Retina Implications for Targeting Diabetic Retinopathy
Sayon Roy et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Effects of the combined extracts of Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide
Xiufeng Tang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Sharon D. Solomon et al.
DIABETES CARE (2017)
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010
Janet L. Leasher et al.
DIABETES CARE (2016)
Is GLP-1 a hormone: Whether and When?
David D'Alessio
JOURNAL OF DIABETES INVESTIGATION (2016)
Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats
Yichao Fan et al.
EXPERIMENTAL EYE RESEARCH (2014)
Muller Glial Cells Inhibit Proliferation of Retinal Endothelial Cells via TGF-β2 and Smad Signaling
Yousef Yafai et al.
GLIA (2014)
Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy
Rob J. Van Geest et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)
Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
Jie Ding et al.
CURRENT DIABETES REPORTS (2012)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
Effect of Pigment Epithelium-Derived Factor on Glutamate Uptake in Retinal Muller Cells under High-Glucose Conditions
Bing Xie et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Intravitreal Injection of Exendin-4 Analogue Protects Retinal Cells in Early Diabetic Rats
Yu Zhang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Protection of exendin-4 analogue in early experimental diabetic retinopathy
Yu Zhang et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Exenatide: Its position in the treatment of type 2 diabetes
B. Guerci et al.
ANNALES D ENDOCRINOLOGIE (2008)
Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells
P. Schlatter et al.
REGULATORY PEPTIDES (2007)
Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin
James F. List et al.
REGULATORY PEPTIDES (2006)
Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Rafael Simo et al.
CURRENT DIABETES REVIEWS (2006)
The role of growth factors in the pathogenesis of diabetic retinopathy
MB Grant et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
JJ Holst
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)